Eric Prommer

Summary

Country: USA

Publications

  1. ncbi request reprint Management of bleeding in the terminally ill patient
    Eric Prommer
    UCLA School of Medicine, Division of Hematology Oncology, VIP Palliative Care Program, Greater Los Angeles Healthcare, 11301 Wilshire 111 H, Los Angeles, CA, USA
    Hematology 10:167-75. 2005
  2. ncbi request reprint Levorphanol: the forgotten opioid
    Eric Prommer
    VIP Palliative Care Program, Greater Los Angeles Healthcare, Division of Hematology Oncology, UCLA School of Medicine, 11301 Wilshire 111 H, Los Angeles, CA, USA
    Support Care Cancer 15:259-64. 2007
  3. ncbi request reprint Rotating methadone to other opioids: a lesson in the mechanisms of opioid tolerance and opioid-induced pain
    Eric Prommer
    UCLA School of Medicine, Division of Hematology Oncology, VIP Palliative Care Program, Greater Los Angeles Healthcare, 90073, USA
    J Palliat Med 9:488-93. 2006
  4. ncbi request reprint Aprepitant (EMEND): the role of substance P in nausea and vomiting
    Eric Prommer
    UCLA School of Medicine, Division of Hematology Oncology, Los Angeles, CA 90073, USA
    J Pain Palliat Care Pharmacother 19:31-9. 2005
  5. ncbi request reprint Palliative care case report: leptomeningeal carcinomatosis
    Eric Prommer
    Hematology Oncology Veterans Intergerated Palliative Care Program, Greater Los Angeles Healthcare, Los Angeles, California 90073, USA
    J Palliat Med 9:1000-7. 2006
  6. ncbi request reprint Oxymorphone: a review
    Eric Prommer
    VIP Palliative Care Program Greater Los Angeles Healthcare, Division of Hematology Oncology, UCLA School of Medicine, 11301 Wilshire 111 H, Los Angeles, CA, USA
    Support Care Cancer 14:109-15. 2006
  7. ncbi request reprint Ziconotide: a new option for refractory pain
    Eric Prommer
    Division of Hematology Oncology, Veterans Integrated Palliative Care Program, UCLA School of Medicine, Los Angeles, California 90073, USA
    Drugs Today (Barc) 42:369-78. 2006
  8. doi request reprint Methylphenidate: established and expanding roles in symptom management
    Eric Prommer
    Division of Hematology Oncology, Mayo Clinic College of Medicine, Scottsdale, AZ, USA
    Am J Hosp Palliat Care 29:483-90. 2012
  9. ncbi request reprint Modafinil: is it ready for prime time?
    Eric Prommer
    UCLA School of Medicine, Division of Hematology Oncology, Los Angeles, CA, USA
    J Opioid Manag 2:130-6. 2006
  10. doi request reprint Calcineurin-inhibitor pain syndrome
    Eric Prommer
    Division of Hematology Oncology, Mayo Clinic College of Medicine, Mayo Clinic Hospital, 5777 E Mayo Boulevard, Scottsdale, AZ 85054, USA
    Clin J Pain 28:556-9. 2012

Detail Information

Publications17

  1. ncbi request reprint Management of bleeding in the terminally ill patient
    Eric Prommer
    UCLA School of Medicine, Division of Hematology Oncology, VIP Palliative Care Program, Greater Los Angeles Healthcare, 11301 Wilshire 111 H, Los Angeles, CA, USA
    Hematology 10:167-75. 2005
    ..This session will review the types of cancer associated with bleeding, as well as management options for these situations. Emphasis will be placed on aspects of communication with families...
  2. ncbi request reprint Levorphanol: the forgotten opioid
    Eric Prommer
    VIP Palliative Care Program, Greater Los Angeles Healthcare, Division of Hematology Oncology, UCLA School of Medicine, 11301 Wilshire 111 H, Los Angeles, CA, USA
    Support Care Cancer 15:259-64. 2007
    ..Similar to morphine, levorphanol undergoes glucuronidation in the liver, and the glucuronidated products are excreted in the kidney. Levorphanol can be given orally, intravenously, and subcutaneously...
  3. ncbi request reprint Rotating methadone to other opioids: a lesson in the mechanisms of opioid tolerance and opioid-induced pain
    Eric Prommer
    UCLA School of Medicine, Division of Hematology Oncology, VIP Palliative Care Program, Greater Los Angeles Healthcare, 90073, USA
    J Palliat Med 9:488-93. 2006
  4. ncbi request reprint Aprepitant (EMEND): the role of substance P in nausea and vomiting
    Eric Prommer
    UCLA School of Medicine, Division of Hematology Oncology, Los Angeles, CA 90073, USA
    J Pain Palliat Care Pharmacother 19:31-9. 2005
    ..Its broad range of activity against a wide variety of central and peripheral emetogenic stimuli make it potentially useful in non-chemotherapy related nausea and vomiting...
  5. ncbi request reprint Palliative care case report: leptomeningeal carcinomatosis
    Eric Prommer
    Hematology Oncology Veterans Intergerated Palliative Care Program, Greater Los Angeles Healthcare, Los Angeles, California 90073, USA
    J Palliat Med 9:1000-7. 2006
  6. ncbi request reprint Oxymorphone: a review
    Eric Prommer
    VIP Palliative Care Program Greater Los Angeles Healthcare, Division of Hematology Oncology, UCLA School of Medicine, 11301 Wilshire 111 H, Los Angeles, CA, USA
    Support Care Cancer 14:109-15. 2006
    ..This article reviews the pharmacodynamics, pharmacology, and clinical efficacy for this new option in treating moderate to severe pain...
  7. ncbi request reprint Ziconotide: a new option for refractory pain
    Eric Prommer
    Division of Hematology Oncology, Veterans Integrated Palliative Care Program, UCLA School of Medicine, Los Angeles, California 90073, USA
    Drugs Today (Barc) 42:369-78. 2006
    ..Ziconotide, formerly known also as SNX- 111, represents a new class of agents, the N-type calcium channel blockers. These may represent another option for patients with refractory pain and refractory pain syndromes...
  8. doi request reprint Methylphenidate: established and expanding roles in symptom management
    Eric Prommer
    Division of Hematology Oncology, Mayo Clinic College of Medicine, Scottsdale, AZ, USA
    Am J Hosp Palliat Care 29:483-90. 2012
    ..This article reviews the current use of methylphenidate for symptom management with a critical look at the evidence base for its efficacy in the conditions described...
  9. ncbi request reprint Modafinil: is it ready for prime time?
    Eric Prommer
    UCLA School of Medicine, Division of Hematology Oncology, Los Angeles, CA, USA
    J Opioid Manag 2:130-6. 2006
    ..Specifically, large placebo-controlled trials with modafinil must be conducted in patients with cancer, with specific attention paid to pain control, depression, cognitive function, and adverse effects...
  10. doi request reprint Calcineurin-inhibitor pain syndrome
    Eric Prommer
    Division of Hematology Oncology, Mayo Clinic College of Medicine, Mayo Clinic Hospital, 5777 E Mayo Boulevard, Scottsdale, AZ 85054, USA
    Clin J Pain 28:556-9. 2012
    ....
  11. ncbi request reprint Gefitinib: a new agent in palliative care
    Eric Prommer
    Department of Medicine, UCLA School of Medicine, Division of Hematology Oncology, and Veterans Integrated Program, GLA Healthcare, Los Angeles, California, USA
    Am J Hosp Palliat Care 21:222-7. 2004
    ..However, further studies are needed to compare gefitinib's ability to control symptoms with intensive palliative modalities for lung cancer, such as opioids, oxygen, and radiation therapy...
  12. ncbi request reprint Ketamine to control pain
    Eric Prommer
    Division of Hematology Oncology, Department of Medicine, VA Greater Los Angeles Health Care System, Los Angeles, California 90073, USA
    J Palliat Med 6:443-6. 2003
  13. ncbi request reprint Re: Olanzapine-induced delirium
    Eric Prommer
    J Pain Symptom Manage 29:119-20. 2005
  14. ncbi request reprint Ketamine and HTLV-1 myelopathy: NMDA blockade and immunomodulation?
    Eric Prommer
    J Pain Symptom Manage 31:386-8; author reply 388-9. 2006
  15. ncbi request reprint Musical hallucinations and opioids: a word of caution
    Eric Prommer
    J Pain Symptom Manage 30:305-7. 2005
  16. ncbi request reprint Re: Pruritus in patients with advanced cancer
    Eric Prommer
    J Pain Symptom Manage 30:201-2. 2005
  17. ncbi request reprint Opioid withdrawal: creating more problems
    Eric Prommer
    J Pain Symptom Manage 33:114-5. 2007